Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo

Molecular and Cellular Biology

Volumn 18, Issue 5, 1998, Pages 2965-2975

  Lamontagne Jr , Kenneth R ^a,b   Flint, Andrew J ^a,e   Franza Jr , B Robert ^c   Pendergast, Ann Marie ^d   Tonks, Nicholas K ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Charybdis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DEPHOSPHORYLATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 2642671984     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.5.2965     Document Type: Article

References (64)

1. Ahmad, F., P.-M. Li, J. Meyerovitch, and B. J. Goldstein. 1995. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J. Biol. Chem. 270:20503-20508.
2. Barford, D., A. J. Flint, and N. K. Tonks. 1994. Crystal structure of human protein tyrosine phosphatase 1B. Science 263:1397-1404.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Brown-Shimer, S., K. A. Johnson, J. B. Lawrence, C. Johnson, and A. Bruskin. 1990. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase. Proc. Natl. Acad. Sci. USA 87:5148-5152.
5. dok: a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204.
6. Chernoff, J., A. R. Schievella, C. A. Jost, R. L. Erikson, and B. G. Neel. 1990. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA 87:2735-2739.
7. Clarkson, B., and A. Strife. 1993. Linkage of proliferative and maturational abnormalties in chronic myelogenous leukemia and relevance to treatment. Leukemia 7:1683-1721.
8. Cortez, D., L. Kadlec, and A. M. Pendergast. 1995. Structural and signaling requirements for Bcr-Abl-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15:5531-5541.
9. bcr/abl protein. Proc. Natl. Acad. Sci. USA 85:9312-9316.
10. bcr/abl gene of the Philadelphia chromosome. Science 247:824-830.
11. Danhauser-Riedl, S., M. Warmuth, B. J. Druker, B. Emmerich, and M. Hallek. 1996. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res. 56:3589-3596.
12. de Jong, R., J. ten Hoeve, N. Heisterkamp, and J. Groffen. 1995. Crk1 is complexed with tyrosine-phosphorylated Cb1 in Ph-positive leukemia. J. Biol. Chem. 270:21468-21471.
13. Denu, J. M., D. L. Lohse, J. Vijayalakshmi, M. A. Saper, and J. E. Dixon. 1996. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc. Natl. Acad. Sci. USA 93:2493-2498.
14. Elefanty, A. G., I. K. Hariharan, and S. Cory. 1990. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 9:1069-1078.
15. Flint, A. J., T. Tiganis, D. Barford, and N. K. Tonks. 1997. Development of "substrate trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 94:1680-1685.
16. Frangioni, J. V., P. H. Beahm, V. Shifrin, C. A. Jost, and B. G. Neel. 1992. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68:545-560.
17. cas as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol. Cell. Biol. 16:6408-6418.
18. Gelderloos, J. A., and S. M. Anderson. 1996. Over-expression of protein tyrosine phosphatase 1 (PTP1) alters IL-3-dependent growth and tyrosine phosphorylation. Oncogene 13:2367-2378.
19. Gishizky, M. L., D. Cortez, and A. M. Pendergast. 1995. Mutant forms of growth factor-binding protein-2 reverse Bcr-Abl-induced transformation. Proc Natl. Acad. Sci. USA 92:10889-10893.
20. Goga, A., J. McLaughlin, D. E. H. Afar, D. C. Saffran, and O. N. Witte. 1995. Alternative signals to ras for hematopoietic transformation by the bcr/abl oncogene. Cell 82:981-988.
21. Guan, K. L., R. S. Haun, S. J. Watson, R. L. Geahlen, and J. E. Dixon. 1990. Cloning and expression of a protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA 87:1501-1505.
22. Hannig, G., S. Ottilie, and R. L. Erikson. 1994. Negative regulation of mitosis in fission yeast by catalytically inactive pyp1 and pyp2 mutants. Proc. Natl Acad. Sci. USA 91:10084-10088.
23. Hariharan, I. K., J. M. Adams, and S. Cory. 1988. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 3:387-399.
24. Huyer, G., S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M. J. Gresser, and C. Ramachandran. 1997. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272:843-851.
25. Jain, S. K., M. Susa, M. L. Keeler, N. Carlesso, B. Druker, and L. Varticovski. 1996. PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p120 BCR/abl. Blood 88:1542-1550.
26. Jia, Z., D. Barford, A. J. Flint, and N. K. Tonks. 1995. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268:1754-1758.
27. Kelliher, M. A., J. McLaughlin, O. N. Witte, and N. Rosenberg. 1990. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc. Natl. Acad. Sci. USA 87:6649-6653.
28. Kenner, K. A., E. Anyanwu, J. M. Olefsky, and J. Kusari. 1996. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J. Biol. Chem. 271:19810-19816.
29. Kurzrock, R., J. U. Gutterman, and M. Talpaz. 1988. The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 319:990-998.
30. Liu, J., Y. Wu, G. Z. Ma, D. Lu, L. Haataja, N. Heisterkamp, J. Groffen, and R. B. Arlinghaus. 1996. Inhibition of Bcr serine kinase by tyrosine phosphorylation. Mol. Cell. Biol. 16:998-1005.
31. Lorenzen, J. A., C. Y. Dadabay, and E. H. Fischer. 1995. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J. Cell Biol. 131:631-643.
32. Lugo, T. G., and O. N. Witte. 1989. The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol. Cell. Biol. 9:1263-1270.
33. Matsuguchi, T., R. C. Inhorn, N. Carlesso, G. Xu, B. Druker, and J. D. Griffin. 1995. Tyrosine phosphorylation of p95vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210bcr/abl. EMBO J. 14:257-265.
34. Matulonis, U., R. Salgia, K. Okuda, B. Druker, and J. D. Griffin. 1993. Interleukin-3 and p210 Bcr/Abl activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp. Hematol. 21:1460-1466.
35. Milarski, K. L., G. Zhu, C. G. Pearl, D. J. McNamara, E. M. Dobrusin, D. MacLean, A. Thieme-Sefler, Z.-Y. Zhang, T. Sawyer, S. J. Decker, J. E. Dixon, and A. R. Saltiel. 1993. Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B. J. Biol. Chem. 268:23634-23639.
36. Mosinger, B. J., U. Tillmann, H. Westphal, and M. L. Tremblay. 1992. Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA 89:499-503.
37. iα2. Nature 379:840-844.
38. Neel, B. G. 1993. Structure and function of SH2-domain containing tyrosine phosphatases. Semin. Cell Biol. 4:419-432.
39. Nishimura, J., J. Okamura, K. Shibata, H. Takahira, Y. Yufu, S. Kato, J. Hirata, T. Umemura, and H. Nawata. 1991. Two bcr/abl fusion gene products, p210bcr/abl and p190bcr/abl, are equally sensitive to the protein tyrosine phosphatase of mature granulocytes. Int. J. Hematol. 54:471-478.
40. Nitta, V., Y. Kato, A. Strife, M. Wachter, J. Fried, A. Perez, S. Jhanwar, R. Duigou-Osterndorf, R. S. K. Chaganti, and B. Clarkson. 1985. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 66:1053-1061.
41. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. Bcr-abl-induced oncogenesis is mediated by direct interaction with the SH2 domain of the Grb-2 adaptor protein. Cell 75:175-185.
42. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. BCR-ABL oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764-773.
43. Raffel, G. D., K. Parmar, and N. Rosenberg. 1996. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:4640-4645.
44. Salgia, R., M. Sattler, E. Pisick, J. L. Li, and J. D. Griffin. 1996. p210 BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl. Exp. Hematol. 24:310-313.
45. Sattler, M., R. Salgia, K. Okuda, N. Uemura, M. A. Durstin, E. Pisick, G. Xu, J.-L. Li, K. V. Prasad, and J. D. Griffin. 1996. The proto-oncogene product p120CBL and the adaptor proteins CRKL and C-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12:839-846.
46. Sawyers, C. L., J. McLaughlin, and O. N. Witte. 1995. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J. Exp. Med. 181:307-313.
47. Schweighoffer, F., I. Barlat, M.-C. Chevallier-Multon, and B. Tocque. 1992. Implication of GAP in ras-dependent transactivation of a polyoma enhancer sequence. Science 256:825-827.
48. Shiozaki, K., and P. Russell. 1995. Cell-cycle control linked to extracellular environment by MAP kinase pathway in fission yeast. Nature 378:739-743.
49. Sirard, C., P. Laneuville, and J. E. Dick. 1994. Expression of bcr-abl abrogates factor-dependent growth of human hematopoetic MO7E cells by an autocrine mechanism. Blood 83:1575-1585.
50. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493.
51. Tauchi, T., G.-S. Feng, R. Shen, H. Y. Song, D. Donner, T. Pawson, and H. E. Broxmeyer. 1994. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J. Biol. Chem. 269:15381-15387.
52. Thomas, M. L. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339-369.
53. Tiganis, T., A. J. Flint, S. A. Adam, and N. K. Tonks. 1996. Association of the T-cell protein tyrosine phosphatase with the nuclear import factor p97. J. Biol. Chem. 272:21548-21557.
54. Tonks, N. K. 1993. Characterization of protein (tyrosine) phosphatases, p. 231-252. In D. G. Hardie (ed.), Protein phosphorylation: a practical approach. IRL Press, Oxford, England.
55. Tonks, N. K., C. D. Diltz, and E. H. Fischer. 1988c. Characterization of the major protein tyrosine phosphatases of human placenta. J. Biol. Chem. 263:6731-6737.
56. Tonks, N. K., C. D. Diltz, and E. H. Fischer. 1988b. Purification of the major protein-tyrosine phosphatases of human placenta. J. Biol. Chem. 263:6722-6730.
57. Tonks, N. K., and B. G. Neel. 1996. From form to function: signaling by protein tyrosine phosphatases. Cell 87:1-20.
58. Uhler, M. D., and G. S. McKnight. 1987. Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase. J. Biol. Chem. 262:15202-15207.
59. Wiener, J. R., S. K. Kassim, Y. Yu, G. B. Mills, and R. C. Bast. 1996. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B and PTP-α expression. Gyn. Oncol. 61:233-240.
60. Woodford-Thomas, T. A., J. D. Rhodes, and J. E. Dixon. 1992. Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J. Cell Biol. 117:401-414.
61. Yamanashi, Y., and D. Baltimore. 1997. Identification of the Abl- and ras-GAP-associated 62 kDa protein as a docking protein, Dok. Cell 88:205-211.
62. Zander, N. F., J. A. Lorenzen, D. E. Cool, N. K. Tonks, G. Daum, E. G. Krebs, and E. H. Fischer. 1991. Purification and characterization of a human recombinant T-cell protein-tyrosine-phosphatase from a baculovirus expression system. Biochemistry 30:6964-6970.
63. Zhai, Y.-F., H. Beittenmiller, B. Wang, M. N. Gould, C. Oakley, W. J. Esselman, and C. W. Welsch. 1993. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 53:2272-2278.
64. Zou, X., S. Rudchenko, K.-K. Wong, and K. Calame. 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654-662.